FDA Warning Letter — Chevron

Case 517695 — FEI 3011315693

The FDA took a Warning Letter action against Chevron on Feb 16, 2017 (Gulf Breeze, FL). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Chevron
Date
Feb 16, 2017
Fiscal Year
2017
Product Type
Tobacco
Center
CTP
Location
Gulf Breeze, FL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.